Clinical

Dataset Information

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma


ABSTRACT: The purpose of this study is to evaluate the safety, tolerability, and efficacy of JX-594 (Pexa-Vec) administered intravenously either alone or in combination with Irinotecan in colorectal carcinoma patients who are refractory to or intolerant to standard therapy.

DISEASE(S): Colorectal Carcinoma,Carcinoma,Crc,Colon Cancer,Colorectal Cancer,Colorectal Neoplasms,Vaccinia

PROVIDER: 2109815 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR